BROWSE BY TOPIC
- Bad Brokers
- Compliance Concepts
- Investor Protection
- Investments - Unsuitable
- Investments - Strategies
- Investments - Private
- Features/Scandals
- Companies
- Technology/Internet
- Rules & Regulations
- Crimes
- Investments
- Bad Advisors
- Boiler Rooms
- Hirings/Transitions
- Terminations/Cost Cutting
- Regulators
- Wall Street News
- General News
- Donald Trump & Co.
- Lawsuits/Arbitrations
- Regulatory Sanctions
- Big Banks
- People
TRENDING TAGS
Stories of Interest
- Sarah ten Siethoff is New Associate Director of SEC Investment Management Rulemaking Office
- Catherine Keating Appointed CEO of BNY Mellon Wealth Management
- Credit Suisse to Pay $47Mn to Resolve DOJ Asia Probe
- SEC Chair Clayton Goes 'Hat in Hand' Before Congress on 2019 Budget Request
- SEC's Opening Remarks to the Elder Justice Coordinating Council
- Massachusetts Jury Convicts CA Attorney of Securities Fraud
- Deutsche Bank Says 3 Senior Investment Bankers to Leave Firm
- World’s Biggest Hedge Fund Reportedly ‘Bearish On Financial Assets’
- SEC Fines Constant Contact, Popular Email Marketer, for Overstating Subscriber Numbers
- SocGen Agrees to Pay $1.3 Billion to End Libya, Libor Probes
- Cryptocurrency Exchange Bitfinex Briefly Halts Trading After Cyber Attack
- SEC Names Valerie Szczepanik Senior Advisor for Digital Assets and Innovation
- SEC Modernizes Delivery of Fund Reports, Seeks Public Feedback on Improving Fund Disclosure
- NYSE Says SEC Plan to Limit Exchange Rebates Would Hurt Investors
- Deutsche Bank faces another challenge with Fed stress test
- Former JPMorgan Broker Files racial discrimination suit against company
- $3.3Mn Winning Bid for Lunch with Warren Buffett
- Julie Erhardt is SEC's New Acting Chief Risk Officer
- Chyhe Becker is SEC's New Acting Chief Economist, Acting Director of Economic and Risk Analysis Division
- Getting a Handle on Virtual Currencies - FINRA
ABOUT FINANCIALISH
We seek to provide information, insights and direction that may enable the Financial Community to effectively and efficiently operate in a regulatory risk-free environment by curating content from all over the web.
Stay Informed with the latest fanancialish news.
SUBSCRIBE FOR
NEWSLETTERS & ALERTS
Orioles Hall of Famer - Investigated for Insider Trading
June 25, 2012
[ by Melanie Gretchen and Howard Haykin ]
A federal insider trading investigation that began in Los Angeles, has moved to Baltimore, MD, where a Hall of Fame slugger for the Orioles baseball team is one of several former professional athletes under investigation. The SEC is participating in this 3-year old investigation, that stems from the buyout of a medical device company.
The Case. Federal prosecutors and securities regulators are trying to determine whether star slugger Eddie Murray traded on inside information that Abbott Laboratories was about to announce a deal in January 2009 to acquire Advanced Medical Optics for $2.8 billion, sources said. Previous reports on the investigation from Los Angeles did not identify any of the players under scrutiny.
Mr. Murray, who has not been charged with any wrongdoing, could not be reached for comment. Michael Proctor, who represents the Hall of Famer in this matter, did not immediately respond to a request for comment. Diane Hock, a lawyer who represents Murray in his post-baseball marketing deals, said she had heard about an investigation, but declined to comment further.
Insider Trading Connection. Mr. Murray came under investigation after a probe led to the filing of a civil insider trading case against former Orioles player Doug DeCinces, with whom he played on the Orioles from 1977 to 1982. In August 2011, DeCinces agreed to pay $2.5 million in fines to settle the case, while neither admitting nor denying wrongdoing in the trading of Advanced Medical Optics shares.
In turn, the DeCinces case was a product of the insider trading investigation that led to the conviction of Galleon Management hedge fund founder Raj Rajaratnam and charges against dozens of traders and corporate consultants. To date, investigators have traced leaks about the Advanced Medical Optics deal to a number of places, including people who worked for the medical device company; its law firm, Skadden Arps; and its merger adviser, Goldman Sachs Group Inc, according to court records and people familiar with that matter.
"We have been aware of these allegations for more than two years, investigated them (and) fully cooperated with federal authorities in the matter." -- A Goldman spokesman.
A Hit Career. Following 10 years as a first baseman for the Orioles, Mr. Murry spent 3 seasons with the Los Angeles Dodgers. Afterward, he was picked up by the New York Mets, the Cleveland Indians and the then-Anaheim Angels. During his career, he hit 504 home runs, making him one of the best switch hitters, who can hit from either side of the plate. Upon retiring, he became the first base coach for the Dodgers and was elected to the Hall of Fame in 2003. For further details, go to: [Reuters, 6/20/12].
